Intermediate-Dose versus Low-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Therapies
Authors:
- Mehdi HamadaniMHMehdi Hamadani
- S. Thomas KochuparambilSKS. Thomas Kochuparambil
- Salman OsmanSOSalman Osman
- Aaron CumpstonACAaron Cumpston
- Sonia LeadmonSLSonia Leadmon
- Pamela BunnerPBPamela Bunner
- Kathy WatkinsKWKathy Watkins
- Devi MorrisonDMDevi Morrison
- Ethan SpeirESEthan Speir
- David DeRemerDDDavid DeRemer
- Vamsi KotaVKVamsi Kota
- Anand JillellaAJAnand Jillella
Open Access
- 1 July 2012
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 18 (7) , 1128-1135
Abstract
No abstract availableKeywords
Funding Information
- Conquer Cancer Foundation of American Society of Clinical Oncology Career Development Award
This publication has 23 references indexed in Scilit:
- Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor Compared to G-CSF and CyclophosphamideTransplantation and Cellular Therapy, 2011
- Chemomobilization with Etoposide is Highly Effective in Patients with Multiple Myeloma and Overcomes the Effects of Age and Prior TherapyTransplantation and Cellular Therapy, 2011
- Effects of induction with novel agentsversusconventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myelomaLeukemia & Lymphoma, 2009
- Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimensBlood, 2009
- Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myelomaBlood, 2009
- Stem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple MyelomaTransplantation and Cellular Therapy, 2008
- Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patientsLeukemia, 2007
- A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agentsBone Marrow Transplantation, 2003
- Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF aloneBone Marrow Transplantation, 1997
- The ISHAGE Guidelines for CD34+ Cell Determination by Flow CytometryJournal of Hematotherapy, 1996